ZAFIRIDE, created in 2013 (Italy), from 7 sister brands. The ZAFIRIDE brand is owned by Molecular Medicine, a company listed in Milan. The International Securities Identification Number (ISIN) of Molecular Medicine is IT0001080248. ZAFIRIDE belongs to the Divers business sector.
Share price and profitability of the share Molecular Medicine (ZAFIRIDE)
Buy Molecular Medicine share with
(0% commission and fractional shares)
Your capital is subject to risk. Other fees apply. For more information, visit etoro.com/trading/fees.
Stock market history Molecular Medicine (ZAFIRIDE)
*non inclusive of dividends, non inclusive of market orders
past performances do not prejudice future performances
past performances do not prejudice future performances
